Combination Therapy In Dyslipidemia - Image 1

£65.57

Adis Combination Therapy In Dyslipidemia

Name: Combination Therapy In Dyslipidemia
Brand: Adis
Price: 65.57 GBP
Availability: InStock

Cardiovascular

This is the most expensive it has ever been. Walk away.

£66 today · previous high £66 · all-time low £65

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 91 days • 91 data points

Historical

Generating forecast...

Price Distribution

Price distribution over 91 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £65 (54 days, 59.3%)

Price range: £65 - £66

Price levels: 2 different prices over 91 days

Description

Comprising contributions from leading lipidologists from around the world, this book presents the latest and most comprehensive knowledge on the different options for combination therapy of dyslipidemia and includes discussion of future therapies that are currently in late stages of clinical evaluation. Dyslipidemia is a leading cause of cardiovascular morbidity and mortality and most patients with this condition fail to achieve adequate control of their serum lipid levels with monotherapy. However, recent US and European guideline recommendations, based on randomized, controlled trials, fail to discuss combination therapy options for patients with dyslipidemia. Statins remain the mainstay of drug therapy for hyperlipidemia and chapters in this book specifically examine the role of add-on therapy with different agents modulating the different lipid fractions in the blood, e.g. bile acid sequestrants, fibric acid derivatives (fibrates), omega-3 fatty acids (fish oils), inhibitors of Niemann-Pick C1 like 1 (NPC1L1) protein, cholesteryl ester transfer protein (CETP), apolipoprotein B-100 and microsomal triglyceride transfer protein (MTP) and the emerging proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. There is additional discussion of the role of non-drug therapy options such as nutraceuticals, functional foods and lipoprotein apheresis. The book also discusses the combination of antihypertensive drugs with lipid-lowering drugs in the management of cardiovascular risk in patents with dyslipidemia. From the Back Cover Comprising contributions from leading lipidologists from around the world, this book presents the latest and most comprehensive knowledge on the different options for combination therapy of dyslipidemia, and includes discussion of future therapies that are currently in late stages of clinical evaluation. Dyslipidemia is a leading cause of cardiovascular morbidity and mortality and most patients with this condition fail to achieve adequate control of their serum lipid levels with monotherapy. However, recent US and European guideline recommendations, based on randomized, controlled trials, fail to discuss combination therapy options for patients with dyslipidemia. Statins remain the mainstay of drug therapy for hyperlipidemia and chapters in this book specifically examine the role of add-on therapy with different agents modulating the different lipid fractions in the blood, e.g. bile acid sequestrants, fibric acid derivatives (fibrates), omega-3 fatty acids (fish oils), inhibitors of Niemann-Pick C1 like 1 (NPC1L1) protein, cholesteryl ester transfer protein (CETP), apolipoprotein B-100 and microsomal triglyceride transfer protein (MTP), and the emerging proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. There is additional discussion of the role of non-drug therapy options such as nutraceuticals, functional foods and lipoprotein apheresis. The book also discusses the combination of antihypertensive drugs with lipid-lowering drugs in the management of cardiovascular risk in patents with dyslipidemia.

Product Specifications

Brand: Adis
Format: paperback
ASIN: 3319367218
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Cardiovascular
Domain: Amazon UK
Release Date: 15 October 2016
Listed Since: 07 October 2016

Barcode

No barcode data available

Adis Combination Therapy In Dyslipidemia

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Disorders of Lipid Metabolism

HMG-CoA Reductase Inhibitors (Milestones in Drug Therapy)

Nutraceuticals and Cardiovascular Disease: An Evidence-based Approach for Clinical Practice (Contemporary Cardiology)

Cardiovascular Diseases: From Molecular Pharmacology to Evidence-Based Therapeutics

High-Density Lipoproteins as Biomarkers and Therapeutic Tools: Volume 1. Impacts of Lifestyle, Diseases, and Environmental Stressors on HDL

Bioactive Lipids in Health and Disease: 1127 (Advances in Experimental Medicine and Biology, 1127)

High-Density Lipoproteins as Biomarkers and Therapeutic Tools: Volume 2. Improvement and Enhancement of HDL and Clinical Applications

Preventive Cardiology: Insights Into the Prevention and Treatment of Cardiovascular Disease (Contemporary Cardiology)

Drug Adherence in Hypertension and Cardiovascular Protection

Angiogenesis and Direct Myocardial Revascularization (Contemporary Cardiology)

Lipidomics: Comprehensive Mass Spectrometry of Lipids (Wiley Series on Mass Spectrometry)

Triglycerides: An Overview (Biochemistry Research Trends)

Dietary Fiber for the Prevention of Cardiovascular Disease: Fiber's Interaction between Gut Microflora, Sugar Metabolism, Weight Control and Cardiovascular Health

Drug Adherence in Hypertension and Cardiovascular Protection

Carotid Artery Stenosis: Current and Emerging Treatments (Neurological Disease and Therapy)

Cardiology Essentials in Clinical Practice

Optimizing Pharmacotherapy in Older Patients: An Interdisciplinary Approach (Practical Issues in Geriatrics)

Adverse Drug Interactions: A Handbook for Prescribers, Second Edition

Interdisciplinary Concepts in Cardiovascular Health: Volume II: Secondary Risk Factors: 2

Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease: A Focus on Early Phase Clinical Drug Development

Oxidative Stress and Vascular Disease: 224 (Developments in Cardiovascular Medicine, 224)

Studies on Atherosclerosis (Oxidative Stress in Applied Basic Research and Clinical Practice)

Lipidomics: Volume 1: Methods and Protocols: 579 (Methods in Molecular Biology, 579)

Antiplatelet Therapy In Ischemic Heart Disease: 4 (American Heart Association Clinical Series)